180 related articles for article (PubMed ID: 24700353)
1. Fine mapping reveals that promotion susceptibility locus 1 (Psl1) is a compound locus with multiple genes that modify susceptibility to skin tumor development.
Angel JM; Abel EL; Riggs PK; McClellan SA; DiGiovanni J
G3 (Bethesda); 2014 Apr; 4(6):1071-9. PubMed ID: 24700353
[TBL] [Abstract][Full Text] [Related]
2. Evidence that Gsta4 modifies susceptibility to skin tumor development in mice and humans.
Abel EL; Angel JM; Riggs PK; Langfield L; Lo HH; Person MD; Awasthi YC; Wang LE; Strom SS; Wei Q; DiGiovanni J
J Natl Cancer Inst; 2010 Nov; 102(21):1663-75. PubMed ID: 20966433
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
Angel JM; Caballero M; DiGiovanni J
Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of the mapping of a 12-O-tetradecanoylphorbol-13-acetate promotion susceptibility locus, Psl1, to distal mouse chromosome 9.
Angel JM; Caballero M; DiGiovanni J
Mol Carcinog; 2001 Dec; 32(4):169-75. PubMed ID: 11746828
[TBL] [Abstract][Full Text] [Related]
5. Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Angel JM; Beltrán L; Minda K; Rupp T; DiGiovanni J
Mol Carcinog; 1997 Oct; 20(2):162-7. PubMed ID: 9364205
[TBL] [Abstract][Full Text] [Related]
6. Genetics of skin tumor promotion.
Angel JM; DiGiovanni J
Prog Exp Tumor Res; 1999; 35():143-57. PubMed ID: 10377758
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression in epidermis of mice sensitive and resistant to phorbol ester skin tumor promotion.
Riggs PK; Angel JM; Abel EL; DiGiovanni J
Mol Carcinog; 2005 Oct; 44(2):122-36. PubMed ID: 16044405
[TBL] [Abstract][Full Text] [Related]
8. Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice.
DiGiovanni J; Imamoto A; Naito M; Walker SE; Beltrán L; Chenicek KJ; Skow L
Carcinogenesis; 1992 Apr; 13(4):525-31. PubMed ID: 1576703
[TBL] [Abstract][Full Text] [Related]
9. Identification of Stmm3 locus conferring resistance to late-stage chemically induced skin papillomas on mouse chromosome 4 by congenic mapping and allele-specific alteration analysis.
Saito M; Okumura K; Miura I; Wakana S; Kominami R; Wakabayashi Y
Exp Anim; 2014; 63(3):339-48. PubMed ID: 25077764
[TBL] [Abstract][Full Text] [Related]
10. Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci.
Peissel B; Zaffaroni D; Pazzaglia S; Manenti G; Zanesi N; Zedda I; Rebessi S; Covelli V; Dragani TA; Saran A
Mamm Genome; 2001 Apr; 12(4):291-4. PubMed ID: 11309660
[TBL] [Abstract][Full Text] [Related]
11. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 x DBA/2) F1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement.
Naito M; Chenicek KJ; Naito Y; DiGiovanni J
Carcinogenesis; 1988 Apr; 9(4):639-45. PubMed ID: 3128409
[TBL] [Abstract][Full Text] [Related]
13. Congenic mapping and allele-specific alteration analysis of Stmm1 locus conferring resistance to early-stage chemically induced skin papillomas.
Okumura K; Saito M; Isogai E; Miura I; Wakana S; Kominami R; Wakabayashi Y
PLoS One; 2014; 9(5):e97201. PubMed ID: 24844776
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene.
Ferraro TN; Golden GT; Smith GG; Martin JF; Lohoff FW; Gieringer TA; Zamboni D; Schwebel CL; Press DM; Kratzer SO; Zhao H; Berrettini WH; Buono RJ
Mamm Genome; 2004 Apr; 15(4):239-51. PubMed ID: 15112102
[TBL] [Abstract][Full Text] [Related]
15. New chemically induced skin tumour susceptibility loci identified in a mouse backcross between FVB and dominant resistant PWK.
Fujiwara K; Igarashi J; Irahara N; Kimura M; Nagase H
BMC Genet; 2007 Jun; 8():39. PubMed ID: 17598916
[TBL] [Abstract][Full Text] [Related]
16. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
Stern MC; Benavides F; LaCava M; Conti CJ
Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363
[TBL] [Abstract][Full Text] [Related]
17. Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus.
de Koning JP; Wakabayashi Y; Nagase H; Mao JH; Balmain A
Oncogene; 2007 Jun; 26(28):4171-8. PubMed ID: 17311004
[TBL] [Abstract][Full Text] [Related]
18. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines.
Wang M; Lemon WJ; Liu G; Wang Y; Iraqi FA; Malkinson AM; You M
Cancer Res; 2003 Jun; 63(12):3317-24. PubMed ID: 12810665
[TBL] [Abstract][Full Text] [Related]
19. Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
Shen J; Abel EL; Riggs PK; Repass J; Hensley SC; Schroeder LJ; Temple A; Chau A; McClellan SA; Rho O; Kiguchi K; Ward MD; Semmes OJ; Person MD; Angel JM; Digiovanni J
Carcinogenesis; 2012 Nov; 33(11):2208-19. PubMed ID: 22782996
[TBL] [Abstract][Full Text] [Related]
20. Mapping of new skin tumor susceptibility loci by a phenotype-driven congenic approach.
Fujiwara K; Inagaki Y; Soma M; Ozaki T; Nagase H
Oncol Lett; 2018 Nov; 16(5):6670-6676. PubMed ID: 30405807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
